GlassScriptPhysician profile
Michael Villeneuve
NPI 1194409177
$993.02
in general payments reported to CMS, 2019-2025
9 companies · $631 in 2025
The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $26.43 · 2024: $335 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $598 · Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $597.89 |
| Food and Beverage | $395.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $285.68 | 2025 | Gore Propaten Vascular Graft |
| Stryker Corporation | $202.72 | 2024 | 1788 |
| Medical Device Business Services, INC. | $137.01 | 2025 | Stratafix |
| Medtronic, INC. | $116.95 | 2025 | Endurant Iis |
| Shockwave Medical, INC | $115.31 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Becton, Dickinson and Company | $77.93 | 2025 | Arista |
| Kci USA, INC. | $26.43 | 2023 | Prevena, Abthera, V.A.C. Veraflo |
| Convatec INC. | $17.16 | 2024 | |
| Boston Scientific Corporation | $13.83 | 2025 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Villeneuve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.